What are the shipping terms and lead times?

Shipping terms include FOB, CFR, CIF, CIP, and EXW. The average lead time is one month during peak seasons.

Which markets does the company export to?

The company exports to South America, Southeast Asia, Africa, Oceania, and the Middle East.

Metronidazole API Raw Material Pharmaceutical Use

Name: Metronidazole API Raw Material Pharmaceutical Use
Brand: Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
SKU: 771363452

Hebei, ChinaShijiazhuang No. 4 Pharmaceutical Co., Ltd.

US$30.00-300.00

100 kg

Sample price:US$1.00/piece.Request sample

Product profile

Customization

Available

Production Line

GMP Approved

Transport Package

Drum

Model NO.

pharmaceutical use

Specification

25kg/drum

Trademark

SHIMEN

Origin

Hebei

HS Code

2933990090

Production Capacity

1000tons

Key features

GMP Approved Production: Manufactured in a GMP approved facility ensuring high quality standards.

Proven Efficacy: Effective against anaerobic infections, septicemia, endocarditis, and colitis.

Established Manufacturer: Produced by Shijiazhuang No.4 Pharmaceutical Co., Ltd., established in 1948.

Global Market Reach: Products exported to South America, Africa, Asia, and other international markets.

High Production Capacity: Large-scale manufacturer with over 3000 employees and leading output volume.

Flexible Payment Terms: Accepts LC and T/T payment methods for secure transactions.

Multiple Shipping Options: Supports FOB, CFR, CIF, CIP, and EXW international commercial terms.

Fast Lead Time: Average lead time of one month during peak seasons for timely delivery.

Company profile

Shijiazhuang No. 4 Pharmaceutical Co., Ltd.

Hebei, China

Business Type: Manufacturer/FactoryExport Year: 2002-01-01Nearest Port: Tianjin Xingang, Qingdao, ShanghaiAverage Response Time: ≤18hTerms of Payment: LC, T/TInternational Commercial Terms(Incoterms): FOB, CFR, CIF, CIP, EXW

AI-Powered supplier vetting

SummaryShijiazhuang No. 4 Pharmaceutical Co., Ltd. is identified as a Chinese public pharmaceutical manufacturer based in Hebei, with products spanning infusion solutions, injections, tablets, capsules, inhalation products, and other medical materials. The supplier reports ISO 9001, ISO 14001, and GMP certifications, more than ten production lines, automated and information-based production and logistics processes, and substantial stated output across several dosage forms. Its export activity began in 2002, although exports represent only 1%–10% of total sales. The company describes integrated R&D, manufacturing, and marketing capabilities, but the provided information does not establish specific after-sales programs, customization services, or named customer cases. Financial strength cannot be assessed because financial data is excluded.

Supplier typeThe supplier is explicitly classified as a Manufacturer/Factory and is described as an integrated pharmaceutical enterprise covering R&D, industrial production, and marketing. Its listed business covers health and medicine products, including injections, infusion solutions, tablets, capsules, and related dosage forms.

CertificationsThe supplier reports ISO 9001, ISO 14001, and GMP certifications. It also states that production is organized strictly according to GMP requirements, providing explicit evidence of formal quality, environmental, and pharmaceutical manufacturing systems.

R&D capabilityThe supplier describes an integrated R&D, production, and marketing model, reports 50 R&D engineers, and states that its production lines integrate leading equipment and technology at an international advanced level. This supports established technical and development capability, although no specific patents, new-product results, or R&D investment details are provided.

Production capacityProduction capability is strongly supported by more than ten production lines, automated and information-based production and logistics processes, and stated annual outputs of 1.5 billion large-volume injection units and 1 billion units each for tablets, capsules, and small-volume injections. The company also reports more than ten international advanced infusion-solution lines and exports through both agency and self-operated channels.

Product Q&A

Q:What is the molecular weight of Metronidazole?

The molecular weight of Metronidazole is 171.15400.

Q:What are the main indications for Metronidazole?

It is used for treating or preventing systemic or local infections caused by anaerobes, including abdominal, digestive, female genital, lower respiratory, skin, soft tissue, bone, and joint infections. It is also effective for septicemia, endocarditis, meningeal infection, antibiotic-induced colitis, and oral anaerobe infections.

Q:What is the physical appearance of Metronidazole?

Metronidazole appears as a white to yellowish crystalline powder.

Q:Who is the manufacturer of this product?

The product is manufactured by Shijiazhuang No.4 Pharmaceutical Co., Ltd., a large-sized foreign invested enterprise established in 1948.

Q:What are the accepted payment terms?

The accepted payment terms are LC (Letter of Credit) and T/T (Telegraphic Transfer).